M&A Deal Summary

DNAPrint Genomics Acquires Ellipsis Biotherapeutics

On December 22, 2005, DNAPrint Genomics acquired life science company Ellipsis Biotherapeutics

Acquisition Highlights

This is DNAPrint Genomics’ 1st transaction in the Life Science sector.
This is DNAPrint Genomics’ 1st transaction in Canada.
This is DNAPrint Genomics’ 1st transaction in Ontario.

M&A Deal Summary
Date	2005-12-22
Target	Ellipsis Biotherapeutics
Sector	Life Science
Buyer(s)	DNAPrint Genomics
Deal Type	Add-on Acquisition

Target

Ellipsis Biotherapeutics

Toronto, Ontario, Canada

Ellipsis Biotherapeutics Corp. is a pharmaceutical company.

Search 201,292 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

DNAPrint Genomics

Sarasota, Florida, United States

Category	Company
Founded	1983
Sector	Life Science
Employees	24

DESCRIPTION

DNAPrint Genomics, Inc. is a developer of genomics-based products and services in two primary markets: biomedical and forensics.

DEAL STATS	#
Overall	1 of 1
Sector (Life Science)	1 of 1
Type (Add-on Acquisition)	1 of 1
State (Ontario)	1 of 1
Country (Canada)	1 of 1
Year (2005)	1 of 1